HeyDonto pulls a $20M seed

HeyDonto, a dental‑data and revenue‑cycle startup, announced a $20 million seed round to scale data exchange and billing tools for dental practices. A large seed check of this size signals investor confidence in healthcare revenue‑cycle automation as a near‑term market with measurable ROI (nationaltoday.com). For angel investors, it’s an example of how regulated, vertical healthcare niches are drawing bigger early bets.

A startup in one of healthcare’s least glamorous corners just raised seed money at a price tag most Series A companies would envy: HeyDonto said on April 7 that it closed a $20 million seed round at a $200 million valuation. The company says the money will scale Conduit, its platform for moving dental data between offices, medical record systems, insurers, patients, and software tools. (newswire.com) Dentists generate piles of records, images, treatment codes, and insurance claims, but much of that information still sits in office-specific practice systems that do not talk cleanly to hospitals or physician networks. HeyDonto is pitching itself as the bridge layer that translates those records into a common format instead of making every office build custom connections one by one. (heydonto.com) (conduitdental.ai) That common format is Fast Healthcare Interoperability Resources, a health-data standard that works like a shared shipping label for medical records. HeyDonto says Conduit uses the Fast Healthcare Interoperability Resources Release 4 standard so dental systems can plug into the same pipes already used across much of the broader healthcare world. (conduitdental.ai) (heydonto.com) The company is not only selling data exchange. Its April 7 announcement says Conduit also handles revenue cycle management, which is the back-office chain that starts with checking insurance and ends with getting paid after a claim is processed. (newswire.com) (nationaltoday.com) That matters because dental billing is unusually fragmented: a practice may juggle procedure codes, insurer rules, attachments, pre-authorizations, and patient balances across separate systems. A tool that cuts even a small amount of claim rework or denial volume can show a return fast, which is why investors often like revenue-cycle software more than products that need years of clinical adoption. (beckersdental.com) (conduitdental.ai) HeyDonto’s website shows three products aimed at that stack: Axiomera for data harmonization, Atlas for visibility across multi-location groups, and Conduit for exchange with outside systems. In plain terms, one product cleans the data, one lets operators see it across offices, and one moves it where it needs to go. (heydonto.com) The company is also leaning hard on intellectual property and standards politics, two things buyers in regulated industries care about. HeyDonto says its platform is built on patented intelligence engines, and its funding announcement says it is a founding member of the Oral Health Interoperability Alliance, a group pushing common technical standards for dental data exchange. (heydonto.com) (markets.financialcontent.com) The size of the round is the real signal here. Crunchbase lists HeyDonto as a company founded in 2024, so a $20 million seed only about two years later suggests investors are treating dental administration as a near-term software market, not a science project. (crunchbase.com) (newswire.com) It also shows where health-tech money is drifting in 2026. Instead of betting only on patient-facing apps or broad “artificial intelligence for healthcare” pitches, investors are writing bigger checks into narrow, regulated workflows where the buyer, the bottleneck, and the payoff are all easy to name: dental records in one place, claims out faster, cash in sooner. (oralhealthgroup.com) (beckersdental.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.